CANTON, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture and commercialization of ...
CHAPEL HILL, NORTH CAROLINA / ACCESS Newswire / February 19, 2025 / Doron Therapeutics, a clinical-stage biotechnology company focusing on degenerative musculoskeletal conditions, today announced that ...
ROCHESTER, Minn.--(BUSINESS WIRE)--RION, at the forefront of exosome innovation and therapeutic application, has officially commenced a Phase 1b study aimed at assessing the efficacy and safety of ...
Approved by the Drug Controller General of India (DCGI), the treatment offers to slow disease progression and promote ...
The MILES study, published in Nature Medicine, showed clinical effectiveness in patients and “confirms an exceptional safety profile” of InGeneron’s cell therapy. At InGeneron, we are dedicated to ...
Cell therapy represents a potential regenerative treatment for osteoarthritis. A recent analysis of all relevant published studies indicates that stem cell transplantation from different sources is ...
Funding over four years will support Phase 1b clinical trial of GNSC-001, as well as phase-appropriate manufacturing activities Osteoarthritis affects more than 30 million Americans, and is leading ...
-- Poster to be presented at American College of Rheumatology Convergence 2025 – BRISBANE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its ...
As per DelveInsight’s assessment, globally, Knee Osteoarthritis pipeline constitutes 50+ key companies continuously working towards developing 60+ Knee Osteoarthritis treatment therapies, analysis of ...
A study released in STEM CELLS Translational Medicine has confirmed the safety of a novel type of cellular therapy for knee pain caused by osteoarthritis. Conducted by a multi-institutional team of ...
An injection that blocks the activity of a protein involved in aging reverses naturally occurring cartilage loss in the knee ...
Stem cell therapy offers a minimally invasive alternative to joint replacement surgery, with recovery times of just one to two weeks compared to months for major surgery Clinical studies show varying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback